{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:48:20Z","timestamp":1769266100540,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11695-019-04212-9","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T14:57:43Z","timestamp":1571324263000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lipoprotein(a) Change After Sleeve Gastrectomy Is Affected by the Presence of Metabolic Syndrome"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1682-3031","authenticated-orcid":false,"given":"Silvia","family":"Paredes","sequence":"first","affiliation":[]},{"given":"Marta","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Maria Lopes","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Olinda","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Ribeiro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"issue":"21","key":"4212_CR1","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","volume":"53","author":"CJ Lavie","year":"2009","unstructured":"Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"4212_CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.med.56.082103.104751","volume":"56","author":"DE Moller","year":"2005","unstructured":"Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med. 2005;56:45\u201362.","journal-title":"Annu Rev Med"},{"issue":"956","key":"4212_CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/pgmj.2004.025601","volume":"81","author":"GD Kolovou","year":"2005","unstructured":"Kolovou GD, Anagnostopoulou KK, Cokkinos DV. Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgrad Med J. 2005;81(956):358\u201366.","journal-title":"Postgrad Med J"},{"issue":"8","key":"4212_CR4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0025-6196(11)60766-0","volume":"83","author":"JA Batsis","year":"2008","unstructured":"Batsis JA, Romero-Corral A, Collazo-Clavell ML, et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc. 2008;83(8):897\u2013907.","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"4212_CR5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/archsurg.139.10.1088","volume":"139","author":"WJ Lee","year":"2004","unstructured":"Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on the metabolic syndrome. Arch Surg. 2004;139(10):1088\u201392.","journal-title":"Arch Surg"},{"issue":"3","key":"4212_CR6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.soard.2016.09.031","volume":"13","author":"AD Van Osdol","year":"2017","unstructured":"Van Osdol AD, Grover BT, Borgert AJ, et al. Impact of laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy on postoperative lipid values. Surg Obes Relat Dis. 2017;13(3):399\u2013403.","journal-title":"Surg Obes Relat Dis"},{"issue":"8","key":"4212_CR7","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s11695-012-0662-8","volume":"22","author":"D Benaiges","year":"2012","unstructured":"Benaiges D, Flores-Le-Roux JA, Pedro-Botet J, et al. Impact of restrictive (sleeve gastrectomy) vs hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile. Obes Surg. 2012;22(8):1268\u201375.","journal-title":"Obes Surg"},{"issue":"1","key":"4212_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12944-018-0794-5","volume":"17","author":"JM Gomez-Martin","year":"2018","unstructured":"Gomez-Martin JM, Balsa JA, Aracil E, et al. Beneficial changes on plasma apolipoproteins A and B, high density lipoproteins and oxidized low density lipoproteins in obese women after bariatric surgery: comparison between gastric bypass and sleeve gastrectomy. Lipids Health Dis. 2018;17(1):145.","journal-title":"Lipids Health Dis"},{"issue":"32","key":"4212_CR9","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/eurheartj\/ehx166","volume":"38","author":"C Waldeyer","year":"2017","unstructured":"Waldeyer C, Makarova N, Zeller T, et al. Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium. Eur Heart J. 2017;38(32):2490\u20138.","journal-title":"Eur Heart J"},{"issue":"6","key":"4212_CR10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.168.6.598","volume":"168","author":"A Bennet","year":"2008","unstructured":"Bennet A, Di Angelantonio E, Erqou S, et al. Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch Intern Med. 2008;168(6):598\u2013608.","journal-title":"Arch Intern Med"},{"issue":"5","key":"4212_CR11","doi-asserted-by":"crossref","first-page":"e0177500","DOI":"10.1371\/journal.pone.0177500","volume":"12","author":"EJ Rhee","year":"2017","unstructured":"Rhee EJ, Cho JH, Lee DY, et al. Insulin resistance contributes more to the increased risk for diabetes development in subjects with low lipoprotein(a) level than insulin secretion. PLoS One. 2017;12(5):e0177500.","journal-title":"PLoS One"},{"issue":"7","key":"4212_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11936-017-0549-z","volume":"19","author":"E Kelly","year":"2017","unstructured":"Kelly E, Hemphill L. Lipoprotein(a): a lipoprotein whose time has come. Curr Treat Options Cardiovasc Med. 2017;19(7):48.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"4212_CR13","doi-asserted-by":"crossref","first-page":"416451","DOI":"10.1155\/2013\/416451","volume":"2013","author":"V Bermudez","year":"2013","unstructured":"Bermudez V, Rojas J, Salazar J, et al. Variations of lipoprotein(a) levels in the metabolic syndrome: a report from the Maracaibo City Metabolic Syndrome Prevalence Study. J Diabetes Res. 2013;2013:416451.","journal-title":"J Diabetes Res"},{"issue":"8","key":"4212_CR14","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1210\/jc.2016-1400","volume":"101","author":"A Vonbank","year":"2016","unstructured":"Vonbank A, Saely CH, Rein P, et al. Lipoprotein (a), the metabolic syndrome and vascular risk in angiographied coronary patients. J Clin Endocrinol Metab. 2016;101(8):3199\u2013203.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"4212_CR15","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.numecd.2013.02.009","volume":"23","author":"KC Sung","year":"2013","unstructured":"Sung KC, Wild SH, Byrne CD. Lipoprotein (a), metabolic syndrome and coronary calcium score in a large occupational cohort. Nutr Metab Cardiovasc Dis. 2013;23(12):1239\u201346.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"4212_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000145541","volume":"54","author":"K Kotani","year":"2008","unstructured":"Kotani K, Shimohiro H, Adachi S, et al. Relationship between lipoprotein(a), metabolic syndrome, and carotid atherosclerosis in older Japanese people. Gerontology. 2008;54(6):361\u20134.","journal-title":"Gerontology"},{"issue":"3","key":"4212_CR17","first-page":"153","volume":"11","author":"DN Kiortsis","year":"2001","unstructured":"Kiortsis DN, Tzotzas T, Giral P, et al. Changes in lipoprotein(a) levels and hormonal correlations during a weight reduction program. Nutr Metab Cardiovasc Dis. 2001;11(3):153\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4212_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1743-7075-3-19","volume":"3","author":"RJ Wood","year":"2006","unstructured":"Wood RJ, Volek JS, Davis SR, et al. Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease. Nutr Metab (Lond). 2006;3:19.","journal-title":"Nutr Metab (Lond)"},{"issue":"6","key":"4212_CR19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00125-017-4246-y","volume":"60","author":"KA Berk","year":"2017","unstructured":"Berk KA, Yahya R, Verhoeven AJM, et al. Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes. Diabetologia. 2017;60(6):989\u201397.","journal-title":"Diabetologia"},{"issue":"1","key":"4212_CR20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.soard.2006.10.003","volume":"3","author":"DB Williams","year":"2007","unstructured":"Williams DB, Hagedorn JC, Lawson EH, et al. Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis. 2007;3(1):8\u201313.","journal-title":"Surg Obes Relat Dis"},{"issue":"10","key":"4212_CR21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s11695-007-9231-y","volume":"17","author":"E Ram","year":"2007","unstructured":"Ram E, Vishne T, Magazanik A, et al. Changes in blood lipid levels following silastic ring vertical gastroplasty. Obes Surg. 2007;17(10):1292\u20136.","journal-title":"Obes Surg"},{"issue":"5","key":"4212_CR22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11695-010-0088-0","volume":"20","author":"GA Woodard","year":"2010","unstructured":"Woodard GA, Peraza J, Bravo S, et al. One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding. Obes Surg. 2010;20(5):578\u201382.","journal-title":"Obes Surg"},{"issue":"5","key":"4212_CR23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000355480","volume":"6","author":"M Fried","year":"2013","unstructured":"Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Facts. 2013;6(5):449\u201368.","journal-title":"Obes Facts"},{"issue":"6","key":"4212_CR24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000442721","volume":"8","author":"V Yumuk","year":"2015","unstructured":"Yumuk V, Tsigos C, Fried M, et al. European guidelines for obesity management in adults. Obes Facts. 2015;8(6):402\u201324.","journal-title":"Obes Facts"},{"issue":"7","key":"4212_CR25","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281\u2013357.","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"4212_CR26","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"DA American","year":"2018","unstructured":"American DA. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13\u201327.","journal-title":"Diabetes Care"},{"issue":"16","key":"4212_CR27","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation."},{"issue":"2","key":"4212_CR28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ijo.2011.100","volume":"36","author":"J Gomez-Ambrosi","year":"2012","unstructured":"Gomez-Ambrosi J, Silva C, Galofre JC, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes. 2012;36(2):286\u201394.","journal-title":"Int J Obes"},{"issue":"2","key":"4212_CR29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3945\/ajcn.2008.26847","volume":"89","author":"KM Flegal","year":"2009","unstructured":"Flegal KM, Shepherd JA, Looker AC, et al. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr. 2009;89(2):500\u20138.","journal-title":"Am J Clin Nutr"},{"key":"4212_CR30","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.2337\/dc07-1248","volume":"30","author":"MF Rivas-Crespo","year":"2007","unstructured":"Rivas-Crespo MF. Comment on Boyko and Jensen. Do we know what homeostatis model assessment measures? If not, does it matter? Diabetes Care. 2007;30:2725\u20138. Diabetes Care. 2015 Dec;38(12):e213","journal-title":"Diabetes Care"},{"issue":"9","key":"4212_CR31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.clinbiochem.2004.03.008","volume":"37","author":"AJ Tremblay","year":"2004","unstructured":"Tremblay AJ, Morrissette H, Gagne JM, et al. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem. 2004;37(9):785\u201390.","journal-title":"Clin Biochem"},{"key":"4212_CR32","first-page":"32","volume":"6","author":"GA Head","year":"2015","unstructured":"Head GA. Cardiovascular and metabolic consequences of obesity. Front Physiol. 2015;6:32.","journal-title":"Front Physiol"},{"issue":"9","key":"4212_CR33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ijo.2011.247","volume":"36","author":"Y Chang","year":"2012","unstructured":"Chang Y, Ryu S, Suh BS, et al. Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. Int J Obes. 2012;36(9):1187\u201394.","journal-title":"Int J Obes"},{"issue":"5","key":"4212_CR34","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00394-018-1743-9","volume":"58","author":"Veronica Davila-Batista","year":"2018","unstructured":"Davila-Batista V, Molina AJ, Vilorio-Marques L, et al. Net contribution and predictive ability of the CUN-BAE body fatness index in relation to cardiometabolic conditions. Eur J Nutr. 2019;58(5):1853\u2013186.","journal-title":"European Journal of Nutrition"},{"issue":"12","key":"4212_CR35","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1007\/s11695-014-1288-9","volume":"24","author":"M Garciacaballero","year":"2014","unstructured":"Garciacaballero M, Reyes-Ortiz A, Garcia M, et al. Changes of body composition in patients with BMI 23-50 after tailored one anastomosis gastric bypass (BAGUA): influence of diabetes and metabolic syndrome. Obes Surg. 2014;24(12):2040\u20137.","journal-title":"Obes Surg"},{"issue":"5","key":"4212_CR36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/meta.2003.50095","volume":"52","author":"M Brochu","year":"2003","unstructured":"Brochu M, Tchernof A, Turner AN, et al. Is there a threshold of visceral fat loss that improves the metabolic profile in obese postmenopausal women? Metabolism. 2003;52(5):599\u2013604.","journal-title":"Metabolism."},{"issue":"Supplementum 1","key":"4212_CR37","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.33549\/physiolres.933583","volume":"66","author":"H Vaverkova","year":"2017","unstructured":"Vaverkova H, Karasek D, Halenka M, et al. Inverse association of lipoprotein (a) with markers of insulin resistance in dyslipidemic subjects. Physiol Res. 2017;66(Supplementum 1):S113\u2013S20.","journal-title":"Physiol Res"},{"issue":"9","key":"4212_CR38","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1172\/JCI45277","volume":"121","author":"I Chennamsetty","year":"2011","unstructured":"Chennamsetty I, Claudel T, Kostner KM, et al. Farnesoid X receptor represses hepatic human APOA gene expression. J Clin Invest. 2011;121(9):3724\u201334.","journal-title":"J Clin Invest"},{"issue":"9","key":"4212_CR39","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2337\/dbi17-0007","volume":"67","author":"N Bozadjieva","year":"2018","unstructured":"Bozadjieva N, Heppner KM, Seeley RJ. Targeting FXR and FGF19 to treat metabolic diseases-lessons learned from bariatric surgery. Diabetes. 2018;67(9):1720\u20138.","journal-title":"Diabetes."},{"key":"4212_CR40","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3389\/fphar.2018.01382","volume":"9","author":"M Ethanic","year":"2018","unstructured":"Ethanic M, Stanimirov B, Pavlovic N, et al. Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome. Front Pharmacol. 2018;9:1382.","journal-title":"Front Pharmacol"},{"issue":"7499","key":"4212_CR41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature13135","volume":"509","author":"KK Ryan","year":"2014","unstructured":"Ryan KK, Tremaroli V, Clemmensen C, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509(7499):183\u20138.","journal-title":"Nature."},{"issue":"4","key":"4212_CR42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bpg.2014.07.004","volume":"28","author":"H Ma","year":"2014","unstructured":"Ma H, Patti ME. Bile acids, obesity, and the metabolic syndrome. Best Pract Res Clin Gastroenterol. 2014;28(4):573\u201383.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"4212_CR43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/joim.12594","volume":"281","author":"M Ghosh Laskar","year":"2017","unstructured":"Ghosh Laskar M, Eriksson M, Rudling M, et al. Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III. J Intern Med. 2017;281(6):575\u201385.","journal-title":"J Intern Med"},{"issue":"6","key":"4212_CR44","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.febslet.2008.02.038","volume":"582","author":"C Langhi","year":"2008","unstructured":"Langhi C, Le May C, Kourimate S, et al. Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes. FEBS Lett. 2008;582(6):949\u201355.","journal-title":"FEBS Lett"},{"issue":"12","key":"4212_CR45","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","volume":"139","author":"ML O\u2019Donoghue","year":"2019","unstructured":"O\u2019Donoghue ML, Fazio S, Giugliano RP, et al. Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk. Circulation. 2019;139(12):1483\u201392.","journal-title":"Circulation."},{"issue":"5","key":"4212_CR46","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/ATVBAHA.111.243055","volume":"32","author":"I Chennamsetty","year":"2012","unstructured":"Chennamsetty I, Claudel T, Kostner KM, et al. FGF19 signaling cascade suppresses APOA gene expression. Arterioscler Thromb Vasc Biol. 2012;32(5):1220\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"4212_CR47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ijo.2014.76","volume":"39","author":"JM Gallego-Escuredo","year":"2015","unstructured":"Gallego-Escuredo JM, Gomez-Ambrosi J, Catalan V, et al. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Int J Obes. 2015;39(1):121\u20139.","journal-title":"Int J Obes"},{"issue":"3","key":"4212_CR48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1194\/jlr.E066985","volume":"57","author":"JL Witztum","year":"2016","unstructured":"Witztum JL, Ginsberg HN. Lipoprotein (a): coming of age at last. J Lipid Res. 2016;57(3):336\u20139.","journal-title":"J Lipid Res"},{"issue":"12","key":"4212_CR49","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.clinbiochem.2014.04.025","volume":"47","author":"T Suzuki","year":"2014","unstructured":"Suzuki T, Aoyama J, Hashimoto M, et al. Correlation between postprandial bile acids and body fat mass in healthy normal-weight subjects. Clin Biochem. 2014;47(12):1128\u201331.","journal-title":"Clin Biochem"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-019-04212-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11695-019-04212-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-019-04212-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T23:57:40Z","timestamp":1602806260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11695-019-04212-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,17]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["4212"],"URL":"https:\/\/doi.org\/10.1007\/s11695-019-04212-9","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,17]]},"assertion":[{"value":"17 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}